BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Insulin Syringes Market Growth 2022-2030: Rising Demand for Insulin Syringes, Due to Increase in Prevalence of Diabetes

  The global insulin syringes market size is expected to reach USD 2.69 Billion in 2030 and register a revenue CAGR of 6.9% over the forecast period, according to latest report by Reports and Data.

  June 14, 2022

   · 

  6 min read
• Mobile Health Market Growth 2022-2030: Rapid Digitalization in The Healthcare Sector

  The Global Mobile Health (mHealth) Market size is estimated to reach USD 310.37 billion by 2027 from USD 51.90 Billion in 2021, delivering a CAGR of 29.5%, according to a new report by Reports and Data.

  June 14, 2022

   · 

  6 min read
• Business

  Philip A. Okala Joins City of Hope as System President

  City of Hope, one of the largest cancer research and treatment organizations in the United States, announced that Philip Okala, chief operating officer at the University of Pennsylvania Health System, will join the organization as system president.

  June 14, 2022

   · 

  5 min read
• VectivBio Announces Pricing of $30 Million Public Offering of Ordinary Shares

  VectivBio Holding AG announced the pricing of a follow-on public offering of 5,715,000 ordinary shares at a public offering price of $5.25 per share for aggregate gross proceeds of approximately $30 million, before deducting underwriting discounts and commissions and offering expenses.

  June 14, 2022

   · 

  5 min read